SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-022471
Filing Date
2022-06-03
Accepted
2022-06-03 16:51:07
Documents
12
Period of Report
2022-06-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K imra-8k_20220602.htm   iXBRL 8-K 46643
  Complete submission text file 0001564590-22-022471.txt   178778

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imra-20220602.xsd EX-101.SCH 5569
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20220602_lab.xml EX-101.LAB 20072
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20220602_pre.xml EX-101.PRE 11919
6 EXTRACTED XBRL INSTANCE DOCUMENT imra-8k_20220602_htm.xml XML 3665
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 22995377
SIC: 2834 Pharmaceutical Preparations